Physician profile
Bennett King
NPI 1366068017
$2,940.54
in general payments reported to CMS, 2019-2025
19 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $656 · 2023: $1,033 · 2024: $547 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $407.37 | 2022-2024 | Augment Injectable, Ortholoc 2 Lapifuse, Actishield |
| Smith+Nephew, INC. | $342.99 | 2021-2024 | Stravix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Maverick |
| Integra Lifesciences Corporation | $294.76 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $294.11 | 2021-2022 | |
| Kerecis Limited | $255.13 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $234.11 | 2024-2025 | Puraply Wound Matrix, Cygnus Dual |
| Acera Surgical, INC. | $170.98 | 2023-2024 | Restrata Wound Matrix |
| Innovation Technologies INC | $167.18 | 2023-2025 | Irrisept |
| Medline Industries Lp | $165.23 | 2023 | |
| Horizon Therapeutics Plc | $126.68 | 2021 | |
| Melinta Therapeutics, LLC | $124.12 | 2022 | |
| Depuy Synthes Sales INC. | $111.27 | 2023 | Motoband |
| Mimedx Group, INC. | $75.68 | 2025 | |
| Orthofix Medical, INC. | $41.17 | 2025 | Physio-Stim |
| Solventum Corporation | $35.29 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Coban |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $27.40 | 2025 | Magellan |
| Paratek Pharmaceuticals, INC. | $24.05 | 2025 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $21.67 | 2025 | |
| Abbvie INC. | $21.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.